
Center for Cancer Research, Comprehensive Cancer Center
Position: Research Associate (Postdoc)
ORCID: 0000-0003-0987-0208
T +43 1 40160 - 57577
Keywords
Colorectal Neoplasms; Immune System; Immunotherapy; Tumor Microenvironment
Research interests
- Humanized mouse models for translational cancer research and immunotherapy
- Stromal regulation of immune cell development and anti-tumor immunity
- Long noncoding RNA regulation of adaptive and anti-tumor immunity
Techniques, methods & infrastructure
- Next-generation humanized mouse models
- Patient-derived tumor xenografts
- Cancer immunotherapies
- Fate reporter and conditional knockout mouse models
- scRNA-seq
- 30+ color full spectrum flow cytometry
- Multiplex immunohistochemistry
Selected publications
- Herndler-Brandstetter*, Ishigame* et al. (2018) KLRG1 + Effector CD8 + T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity. Immunity, 48(4), pp.716-729.e8. Available at: http://dx.doi.org/10.1016/j.immuni.2018.03.015.
- Ring*, Herndler-Brandstetter*, Weiskopf* et al. (2017) Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity. PNAS, 114(49), pp.E10578-E10585. Available at: http://dx.doi.org/10.1073/pnas.1710877114.
- Herndler-Brandstetter*, Shan* et al. (2017) Humanized mouse model supports development, function, and tissue residency of human natural killer cells. PNAS, 114(45), pp.E9626-E9634. Available at: http://dx.doi.org/10.1073/pnas.1705301114.
- Shan, Flavell and Herndler-Brandstetter (2022) ‘Development of Humanized Mouse Models for Studying Human NK Cells in Health and Disease’, Methods Mol Biol, 2463, pp.53-66. Available at: http://dx.doi.org/10.1007/978-1-0716-2160-8_5.
- Moritsch et al. (2022) ‘Tyk2 is a tumor suppressor in colorectal cancer’, OncoImmunology, 11(1). Available at: http://dx.doi.org/10.1080/2162402x.2022.2127271.